EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting

Mengting Li, Haotian Fei, Liang Huang, Lu Qing, Xiaoliang Liu, Guoyan Lu

Frontiers in Pharmacology · 24.08.2026 · 17

DOI: 10.3389/fphar.2026.1905442 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.08.2026. Verfasst von Mengting Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ministry of Education Key Laboratory of Women and Children's Diseases and Birth Defects, West China Second University Hospi…. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric data for sulbactam-durlobactam (SUL-DUR) are extremely scarce, and no standard pediatric dosing exists.

Methods

We report a 6-year-old boy with cerebral palsy and epilepsy who developed recurrent ventilator-associated pneumonia caused by OXA-23-producing carbapenem-resistant Acinetobacter baumannii (CRAB).

Results

Due to financial constraints, a reduced-dose SUL-DUR regimen (150 mg/kg/day, q6h, 3-h infusion) was combined with cefoperazone-sulbactam to achieve a total sulbactam dose of 150 mg/kg/day. The patient defervesced within 48 h, inflammatory markers declined, chest imaging improved markedly, and he was transferred out of the PICU after 12 days of therapy.

Conclusion

A PK/PD-driven low-dose SUL-DUR strategy may represent a feasible and potential cost-saving strategy for pediatric CRAB pneumonia in resource-limited settings.

Schlagwörter

Stichwörter der Autor:innen

OXA-23carbapenem-resistant Acinetobacter baumanniilow-dose regimenpediatric pneumoniaresource-limited settingsulbactam-durlobactam

Autor:innen und Institutionen

  • Department of Pediatrics, Ministry of Education Key Laboratory of Women and Children's Diseases and Birth Defects, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Pediatrics, WCSUH-Tianfu·Sichuan Provincial Children's Hospital, Meishan, Sichuan, China.

Zitieren

APA

Li, M., Fei, H., Huang, L., Qing, L., Liu, X., & Lu, G. (2026). Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1905442

Vancouver

Li M, Fei H, Huang L, Qing L, Liu X, Lu G. Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1905442

BibTeX
@article{Li2026,
  author = {Li, Mengting and Fei, Haotian and Huang, Liang and Qing, Lu and Liu, Xiaoliang and Lu, Guoyan},
  title = {Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1905442}
}
Kostenlos starten →